Net income
−$1.1M
+55.8% vs same quarter last year
EPS, diluted
−$0.05
+91.4% vs same quarter last year
Operating cash flow
−$1.4M
+51.4% vs same quarter last year
Operating income
−$1.4M
+46.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$11.1M |
| FY24 | $119.4K | −$8.3M |
| FY23 | $839.4K | −$6.1M |
| FY22 | $948.9K | −$13.8M |
| FY21 | $824.3K | −$12.6M |
| FY20 | $2.4M | −$17.7M |
| FY19 | $4.6M | −$9.4M |
| FY18 | $5.2M | −$8.9M |
| FY17 | $5.4M | −$7.1M |
| FY16 | $10.4M | −$3.2M |
| FY15 | $8.8M | −$7.8M |
| FY14 | $7M | −$6.7M |
| FY13 | $3.2M | −$10.1M |
| FY12 | $3.1M | −$4.2M |
| FY11 | $7.7M | −$2.4M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | 0% | −7907.7% | −6953.1% |
| FY23 | 11.6% | −917.1% | −726.7% |
| FY22 | 42% | −1500.6% | −1454.1% |
| FY21 | 11.6% | −1589.2% | −1522.7% |
| FY20 | 22.8% | −787.7% | −749.7% |
| FY19 | 22.9% | −227.7% | −202.1% |
| FY18 | 12.3% | −172.8% | −169.8% |
| FY17 | 20.7% | −139.8% | −131.6% |
| FY16 | 19.3% | −54.6% | −31.1% |
| FY15 | 21.5% | −81.1% | −89.3% |
| FY14 | 24.6% | −152.8% | −95.2% |
| FY13 | 21.1% | −222% | −312% |
| FY12 | 17.5% | −149.2% | −132.4% |
| FY11 | 72.5% | −38.6% | −31% |
- Soligenix
- Healthcare median
Show the numbers
| Year | Soligenix | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | −6953.1% | −47% |
| FY23 | −726.7% | −58% |
| FY22 | −1454.1% | −80.4% |
| FY21 | −1522.7% | −71.9% |
| FY20 | −749.7% | −62.2% |
| FY19 | −202.1% | −46.3% |
| FY18 | −169.8% | −49.6% |
| FY17 | −131.6% | −45.9% |
| FY16 | −31.1% | −36% |
| FY15 | −89.3% | −38.4% |
| FY14 | −95.2% | −35.5% |
| FY13 | −312% | −37.1% |
| FY12 | −132.4% | −29.1% |
| FY11 | −31% | −27.9% |